Correlation Between Nuvectis Pharma and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Nuvalent, you can compare the effects of market volatilities on Nuvectis Pharma and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Nuvalent.
Diversification Opportunities for Nuvectis Pharma and Nuvalent
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nuvectis and Nuvalent is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Nuvalent go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Nuvalent
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 639.33 times less return on investment than Nuvalent. In addition to that, Nuvectis Pharma is 1.92 times more volatile than Nuvalent. It trades about 0.0 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.04 per unit of volatility. If you would invest 8,749 in Nuvalent on September 10, 2024 and sell it today you would earn a total of 642.00 from holding Nuvalent or generate 7.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Nuvectis Pharma vs. Nuvalent
Performance |
Timeline |
Nuvectis Pharma |
Nuvalent |
Nuvectis Pharma and Nuvalent Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvectis Pharma and Nuvalent
The main advantage of trading using opposite Nuvectis Pharma and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |